Evogene Ltd. Logo

Evogene Ltd.

A computational biology company using AI to develop life-science products.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot

Description

Evogene Ltd. is a computational biology company that leverages artificial intelligence and big data to discover and develop novel life-science products. The company's proprietary Computational Predictive Biology (CPB) platform is designed to optimize the probability of success and reduce the time and cost of development. Evogene operates in the fields of human health, agriculture, and industrial applications. Its technology is organized into three AI-driven engines tailored for specific product types: MicroBoost AI for microbe-based products, ChemPass AI for small molecule-based products, and GeneRator AI for products based on genetic elements. The company's business model involves supporting subsidiary companies that focus on specific commercial fields, utilizing Evogene's technology to bring innovative products to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-12 16:00
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Other Report or Announcement
English 36.5 KB
2025-07-29 16:00
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 217.6 KB
2025-07-29 16:00
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 36.5 KB
2025-07-18 01:00
Other Report or Announcement
English 180.7 KB
2025-07-18 01:00
Other Report or Announcement
English 36.7 KB
2025-07-08 16:00
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 173.8 KB
2025-07-08 16:00
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 36.6 KB
2025-06-18 01:01
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 708.7 KB
2025-06-18 01:01
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 36.4 KB
2025-06-18 01:00
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 140.8 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Evogene Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.